European Medicines Agency (EMA) | What's new Follow Orphan designation: mavorixafor Treatment of WHIM syndrome, 25/07/2019 Positive https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-19-2183 ema.europa.eu
